NIMG-23. A NOVEL APPROACH TO PERFUSION MRI STUDIES IN BRAIN TUMOR PATIENTS USING ENDOGENOUS DEOXYHEMOGLOBIN AS A CONTRAST AGENT: A PROOF-OF-CONCEPT STUDY
Vittorio Stumpo(University of Zurich), Jorn Fierstra(University of Zurich), Athina Pangalu(MACOM (United States)), Joseph A. Fisher(University Health Network), Christiaan Hendrik Bas van Niftrik(University of Zurich), Martina Sebök(University of Zurich), Jacopo Bellomo(University Hospital Zurich), Zsolt Kulcsár(University of Zurich), Olivia Sobczyk(University Health Network), Luca Regli(University of Zurich), Andrea Bink(University of Zurich), Ece Su Sayin(University Health Network), James Duffin(University of Toronto), Michael Weller(University Hospital of Zurich)
Cited by 0
Related Papers
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
|The Lancet Oncology|2017|1.1k
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
|The Lancet Oncology|2017|1.1k
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994